TMCnet3h
Quince Therapeutics Receives Notice of Allowance Covering Innovative Method of Use for Lead Indication Ataxia-Telangiectasia
Quince Therapeutics, Inc. (Nasdaq: QNCX) is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. For more information on ...
Quince Therapeutics secures USPTO nod for A-T treatment patent
SOUTH SAN FRANCISCO, Calif. - Quince Therapeutics, Inc. (NASDAQ: QNCX), a biotech firm focusing on rare diseases with a current market capitalization of $67.76 million, has received a Notice of ...
Chamberlain Sun6h
I Tested NanoDefense Pro for Toenail Fungus: Here’s My Honest Review
Discover my personal experience with NanoDefense Pro reviews and how it transformed my nail health in just 30 days.